Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief…
<!-- Name:DistributionId Value:1000809655 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
cancer immunotherapy
ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific…
<!-- Name:DistributionId Value:1000805915 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Cancer Immunotherapy Market Size ($674 Bn by 2032 at 13.8% CAGR) Global Analysis by…
<!-- Name:DistributionId Value:8796736 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Evaxion receives FDA fast-track designation for personalized cancer immunotherapy
COPENHAGEN, Denmark, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the…
ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of…
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area),…
Gene Target to Boost Effectiveness of Cancer Immunotherapy Identified
The gene codes for a protein called TANK-binding kinase 1 (TBK1), a multi-functional enzyme with an established role in coordinating innate immune responses to viruses and other invading…
Cancer Immunotherapy With a Novel Small Molecule Easily Available
"In 2018, the Nobel Prize in Medicine was awarded to James Allison and Tasuku Honjo for their contribution to the study of immunotherapy, the treatment of cancer through activation of the…
Bladder Cancer Immunotherapy Response may be Predicted by Genetics
Anti-PD-1/PD-L1 therapy, a type of cancer immunotherapy that opens the door for the body's immune system to attack tumor cells, has demonstrated effectiveness against many cancer types…
Cancer Immunotherapy Modulates Tumor Immunophenotype
Since clinical trials on the first STING agonist, ADU-S100, were suspended in 2020, there is an urgent need to develop new STING activators.
Once the…
Drug Holds Potential in Treating Advanced Endometrial Cancer
Pembrolizumab is a cancer immunotherapy that works by inhibiting certain cellular receptors that prevent the immune system from recognizing and destroying cancer cells.
…